Analysts Bullish on Healthcare Stocks: Labcorp Holdings and Abivax SA Sponsored ADR

Analysts at Bloomberg recommend buying Labcorp Holdings (LH) and Abivax SA Sponsored ADR (ABVX). Labcorp Holdings has a Strong Buy consensus rating with a $297.08 average price target, representing a 6.9% upside. Abivax SA Sponsored ADR also has a Strong Buy consensus rating with a $87.17 price target. Both companies have experienced bullish sentiments from analysts.

Analysts at Bloomberg have recently recommended buying Labcorp Holdings (LH) and Abivax SA Sponsored ADR (ABVX). Both companies have received a Strong Buy consensus rating, with Labcorp Holdings having a $297.08 average price target representing a 6.9% upside, and Abivax SA Sponsored ADR with a $87.17 price target.

Labcorp Holdings, a healthcare diagnostics company, has shown significant growth potential. The company has focused on strategic acquisitions and partnerships to drive revenue growth. In the second quarter of 2025, Labcorp invested $25 million in acquisitions and partnerships, contributing 3.5% to revenue growth. The company has also made notable acquisitions such as Incyte Diagnostics and BioReference Health, which have enhanced its capabilities in key specialty areas like oncology and women's health [1].

Labcorp's operational efficiency initiatives, such as the LaunchPad program, have also contributed to its financial performance. The company has successfully achieved targeted savings of $350 million by the end of 2024 and aims to drive $100-$125 million in savings each year [1].

Abivax SA Sponsored ADR, a biotechnology company, has also received a positive outlook from analysts. LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Abivax SA Sponsored ADR with a price target of $116.00. The company's shares closed last Friday at $77.28, indicating a potential for growth [2].

Both companies have experienced bullish sentiments from analysts, suggesting they are well-positioned for future growth. Investors should closely monitor these companies for potential opportunities.

References:
[1] https://www.nasdaq.com/articles/it-right-time-hold-labcorp-stock-your-portfolio
[2] https://www.theglobeandmail.com/investing/markets/stocks/LH/pressreleases/34385440/analysts-offer-insights-on-healthcare-companies-labcorp-holdings-lh-and-abivax-sa-sponsored-adr-abvx/